Yahoo · Aug 21, 2026
COO vs. MMSI: Which Stock Is the Better Value Option?
COO vs. MMSI: Which Stock Is the Better Value Option?
NASDAQ · COO
The Cooper Companies, Inc.
Healthcare · Medical - Instruments & Supplies
$71.17
Up+$0.21 (+0.30%)
Updated Aug 31, 2026, 11:34 AM
SID Score
4.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 16.38B
- P/E ratio
- 43.38
- Dividend yield
- 0.00%
- 52-week range
- $58.89 – $89.83
- Volume
- 1.01M
- Avg. volume
- 2.86M
Price performance
COO price history
1M range · 20 trading sessions · Daily adjusted prices
COO closed at $71.17 after 20 trading sessions, down 4.12% for the selected period.
- Last close
- $71.17
- Period change
- -4.12%
- Period low
- $70.96
- Period high
- $76.82
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $71.18 | $71.50 | $70.664 | $71.17 | 1.01M |
| Aug 27, 2026 | $71.90 | $72.08 | $70.70 | $70.96 | 1.52M |
| Aug 26, 2026 | $72.62 | $72.93 | $72.2201 | $72.68 | 1.56M |
| Aug 25, 2026 | $75.42 | $75.71 | $72.9214 | $73.04 | 1.43M |
| Aug 24, 2026 | $76.14 | $76.58 | $75.62 | $75.80 | 1.14M |
| Aug 21, 2026 | $76.18 | $76.595 | $75.61 | $76.22 | 1.55M |
| Aug 20, 2026 | $76.47 | $77.09 | $76.11 | $76.16 | 1.09M |
| Aug 19, 2026 | $76.40 | $78.105 | $75.84 | $76.73 | 1.38M |
| Aug 18, 2026 | $76.09 | $76.69 | $75.64 | $75.76 | 1.89M |
| Aug 17, 2026 | $75.57 | $76.14 | $75.01 | $75.10 | 1.93M |
| Aug 14, 2026 | $76.87 | $76.87 | $76.08 | $76.17 | 887.12K |
| Aug 13, 2026 | $77.26 | $77.64 | $76.375 | $76.60 | 1.39M |
| Aug 12, 2026 | $76.34 | $77.19 | $75.37 | $76.73 | 2.95M |
| Aug 11, 2026 | $76.32 | $77.42 | $76.20 | $76.82 | 1.68M |
| Aug 10, 2026 | $74.23 | $76.60 | $74.20 | $76.32 | 2.39M |
| Aug 7, 2026 | $73.05 | $74.58 | $72.65 | $74.23 | 1.56M |
| Aug 6, 2026 | $75.00 | $75.13 | $73.23 | $73.32 | 1.93M |
| Aug 5, 2026 | $74.745 | $75.02 | $73.82 | $74.84 | 1.51M |
| Aug 4, 2026 | $73.91 | $74.80 | $73.27 | $74.69 | 1.97M |
| Aug 3, 2026 | $73.38 | $74.845 | $73.38 | $74.23 | 2.81M |
Latest COO news
The latest Smart Investors Daily articles mentioning COO.
Stock researchCompany · Overview
COO research
Overview
Company profile and research snapshot.
Company profile
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $91.67
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | Citigroup | Neutral | — |
| Jul 28, 2026 | UBS | Neutral | — |
| Jul 8, 2026 | Citigroup | Neutral | — |
| Jun 8, 2026 | BNP Paribas | Outperform | — |
| Jun 5, 2026 | Stifel | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 21, 2026
Is Cooper Companies (COO) Cheap After Slower Growth Forecasts Raised Valuation Concerns?
Analyst projections of slower revenue growth for Cooper Companies (COO), along with past growth projects that did not clear the healthcare sector’s cost of capital, have put the stock’s recent underperformance in sharper focus for investors. See our latest analysis for Cooper Companies. Over the past year Cooper Companies has seen some recovery in its share price, with a 90 day share price return of 21.76% and a 1 year total shareholder return of 1.25%. However, the 3 year and 5 year total...
Yahoo · Aug 21, 2026
Softening Growth And Subpar Returns On Investment Could Be A Game Changer For Cooper (COO)
In recent months, CooperCompanies has faced a softer outlook as analysts now expect its revenue to grow more slowly than in prior years, pointing to potential demand challenges. An important underlying issue is that past growth investments have generated returns below the healthcare industry’s cost of capital, raising fresh questions about how efficiently management is deploying capital. Next, we’ll examine how this weaker revenue growth outlook and capital efficiency concern could reshape...
Yahoo · Aug 20, 2026
Cooper Companies (COO) Stock Trades At A Premium To Fair Value
Cooper Companies stock has delivered a decline of 31.3% over the past five years, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to attractive upside while earnings based multiples suggest the shares are on the expensive side. Over five years, Cooper Companies has fallen 31.3%, which means long term holders are still under water even after more recent gains. The key support for the current valuation is the market's confidence...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
